Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Trophoblast cell surface protein 2 (TROP-2) is a transmembrane glycoprotein involved in calcium signaling and regulation of cell growth, motility, and self-renewal. It is overexpressed in many epithelial cancers and serves as a therapeutic target for antibody-drug conjugates like sacituzumab govitecan. Its expression is also a biomarker for diagnosis, prognosis, and treatment selection.
Antibody-drug conjugate targeting TROP-2, delivering cytotoxic payload SN-38
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Trophoblast cell surface protein 2 (TROP-2).